Author: Yoo, Jeanwoo; Grewal, Prabhjot; Hotelling, Jessica; Papamanoli, Aikaterini; Cao, Kerry; Dhaliwal, Simrat; Jacob, Robin; Mojahedi, Azad; Bloom, Michelle E.; Marcos, Luis A.; Skopicki, Hal A.; Kalogeropoulos, Andreas P.
Title: Admission NTâ€proBNP and outcomes in patients without history of heart failure hospitalized with COVIDâ€19 Cord-id: 0grbmoxx Document date: 2021_8_4
ID: 0grbmoxx
Snippet: AIMS: We examined the value of Nâ€terminal proâ€Bâ€type natriuretic peptide (NTâ€proBNP) in patients admitted for coronavirus disease 2019 (COVIDâ€19) without prior history of heart failure (HF) or cardiomyopathy. METHODS AND RESULTS: Retrospective cohort of consecutive adults (N = 679; median age 59 years; 38.7% women; 87.5% White; 7.1% Black; 5.4% Asian; 34.3% Hispanic) admitted with documented COVIDâ€19 in an academic centre in Long Island, NY. Admission NTâ€proBNP was categorized usin
Document: AIMS: We examined the value of Nâ€terminal proâ€Bâ€type natriuretic peptide (NTâ€proBNP) in patients admitted for coronavirus disease 2019 (COVIDâ€19) without prior history of heart failure (HF) or cardiomyopathy. METHODS AND RESULTS: Retrospective cohort of consecutive adults (N = 679; median age 59 years; 38.7% women; 87.5% White; 7.1% Black; 5.4% Asian; 34.3% Hispanic) admitted with documented COVIDâ€19 in an academic centre in Long Island, NY. Admission NTâ€proBNP was categorized using the European Society of Cardiology Heart Failure Association ageâ€specific criteria for acute presentations. We examined (i) mortality and the composite of death or mechanical ventilation and (ii) outâ€ofâ€hospital, intensive care unit (ICU)â€free, and ventilatorâ€free days at 28 days. Estimates were adjusted for confounders using a lasso selection process. Using ageâ€specific criteria, 417 patients (61.4%) had low, 141 (20.8%) borderline, and 121 (17.8%) high NTâ€proBNP. Mortality was 5.8%, 20.6%, and 36.4% for patients with low, borderline, and high NTâ€proBNP, respectively. In lassoâ€adjusted models, high NTâ€proBNP was associated with higher mortality [hazard ratio (HR) 2.15; 95% confidence interval (CI) 1.06–4.39; P = 0.034] and composite endpoint rates (HR 1.66; 95%CI 1.04–2.66; P = 0.035). Patients with high NTâ€proBNP had 32%, 33%, and 33% fewer outâ€ofâ€hospital, ICUâ€free, and ventilatorâ€free days compared with low NTâ€proBNP counterparts. Results were consistent across age, sex, and race, and regardless of coronary artery disease or hypertension, except for stronger mortality signal with high NTâ€proBNP in women. CONCLUSIONS: In patients with COVIDâ€19 and no HF history, high admission NTâ€proBNP is associated with higher mortality and healthcare resources utilization. Preventive strategies may be required for these patients.
Search related documents:
Co phrase search for related documents- acute kidney injury and adjusted analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- acute kidney injury and adjusted hr: 1, 2, 3, 4, 5, 6, 7, 8
- acute phase and adjusted analysis: 1
- acute phase and adjusted hr: 1
Co phrase search for related documents, hyperlinks ordered by date